Skip to main content

Abstract

Objective:

There is growing evidence that exposure to trauma prior to conception can affect offspring. The authors have reported that adult offspring of Holocaust survivors showed lower methylation of FK506 binding protein 5 (FKBP5) intron 7, site 6 compared with Jewish comparison volunteers. The present study sought to replicate this finding in a larger sample and to examine parental and offspring correlates of observed effects.

Methods:

Cytosine methylation was measured in blood using pyrosequencing. The independent replication sample consisted of 125 Holocaust offspring and 31 control subjects. Additional analyses, performed in a larger sample of 147 offspring and 40 control subjects that included the 31 previously studied participants, examined associations of parental trauma–related variables (i.e., sex of the exposed parent, parental posttraumatic stress disorder, age at Holocaust exposure) and offspring characteristics (i.e., childhood trauma exposure, lifetime psychiatric diagnoses, psychotropic medication use, FKBP5 rs1360780 genotype, FKBP5 gene expression, and neuroendocrine measures) with offspring FKBP5 methylation.

Results:

FKBP5 site 6 methylation was significantly lower in Holocaust offspring than in control subjects, an effect associated with maternal Holocaust exposure in childhood and with lower offspring self-reported anxiety symptoms. FKBP5 gene expression was elevated in Holocaust offspring. FKBP5 methylation was associated with indices of glucocorticoid sensitivity but not with basal FKBP5 gene expression.

Conclusions:

This study replicates and extends the previously observed decrement in FKBP5 intron 7, site 6 methylation in Holocaust offspring. The predominance of this effect in offspring of mothers exposed during childhood implicates maternal developmental programming as a putative mechanism.

Formats available

You can view the full content in the following formats:

Supplementary Material

File (appi.ajp.2019.19060618.ds001.pdf)

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 744 - 753
PubMed: 32312110

History

Received: 13 June 2019
Revision received: 11 December 2019
Accepted: 2 January 2020
Published online: 21 April 2020
Published in print: August 01, 2020

Keywords

  1. Epigenetics
  2. Stress
  3. Intergenerational Trauma
  4. FKBP5
  5. Holocaust
  6. Developmental Programming

Authors

Affiliations

Linda M. Bierer, M.D.
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).
Heather N. Bader, B.S.
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).
Nikolaos P. Daskalakis, M.D., Ph.D.
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).
Amy Lehrner, Ph.D.
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).
Nadine Provençal, Ph.D.
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).
Tobias Wiechmann, M.S.
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).
Torsten Klengel, M.D., Ph.D.
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).
Iouri Makotkine, M.D.
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).
Elisabeth B. Binder, M.D., Ph.D.
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).
Rachel Yehuda, Ph.D. [email protected]
Mental Health Care Center, James J. Peters VA Medical Center, Bronx, N.Y. (Bierer, Bader, Lehrner, Makotkine, Yehuda); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Bierer, Bader, Daskalakis, Lehrner, Makotkine, Yehuda); McLean Hospital, Harvard Medical School, Belmont, Mass. (Daskalakis, Klengel); Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany (Klengel); Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Munich (Provençal, Wiechmann, Binder); Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, and British Columbia Children’s Hospital Research Institute, Vancouver, British Columbia (Provençal); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Binder).

Notes

Send correspondence to Dr. Yehuda ([email protected]).

Competing Interests

Dr. Daskalakis held a part-time paid position at Cohen Veterans Biosciences and has served as a consultant for Sunovion. Dr. Yehuda is named as a coinventor of the patent application “Genes associated with posttraumatic-stress disorder” (European patent 2334816 B1). Dr. Binder is named as a coinventor of the patent application “FKBP5: a novel target for antidepressant therapy” (European patent 1687443 B1). The other authors report no financial relationships with commercial interests.

Funding Information

H2020 European Research Councilhttp://dx.doi.org/10.13039/100010663: 281338, GXEmolmech
National Center for Advancing Translational Scienceshttp://dx.doi.org/10.13039/100006108: UL1 TR000067
National Institute of Mental Healthhttp://dx.doi.org/10.13039/100000025: R01 MH064675, RC1 MH088101
Supported by NIMH grants MH-088101 and MH-064675 to Dr. Yehuda, by European Research Council starting grant 281338 to Dr. Binder, and in part by grant TR-000067 from the National Center for Advancing Translational Sciences, with resources from and the use of facilities at the James J. Peters VA Medical Center, Bronx, N.Y.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share